The global women’s health devices market size was estimated to be USD 51.47 billion in 2023 and is expected to reach at USD 139.25 billion by 2034 with a CAGR of 9.47% during the forecast period 2024-2034. An increase in spending on women's health, a growing awareness of female health issues, surge in disposable incomes among women globally, a heightened prevalence of female cancers such as breast & ovarian cancer, as well as other conditions including uterine fibroids, increasing research & development activities, growing demand for diagnostic & monitoring devices, various investment initiatives being implemented, and rising focus on the development of new women’s health products are some of the key factors boosting the market growth.
Rising focus on the development of new women’s health products is predicted to boost the market growth during the forecast period. Favorable advancements in the field of women's health have inspired a diverse range of companies with various focus areas to invest in the research and development of novel products. Consequently, there has been a notable increase in the number of product launches expected in the forecast period. For instance, in September 2022, Anti-Mullerian Hormone (AMH), a novel direct-to-consumer test, was introduced by Innovative Health Diagnostic.
By application, cancers & other chronic diseases was the highest revenue-grossing segment in the global women’s health devices market in 2023 owing to the growing number of female cancers, the increasing demand for effective medical equipment, and the increasing number of innovative items being released. For instance, in November 2022, Aspira Women's Health introduced OvaWatch to evaluate the risk of ovarian cancer. Additionally, pregnancy & nursing care is predicted to grow at fastest CAGR during the forecast period owing to the growing usage and demand for various essential women's health products, such as breast pumps and pregnancy tests.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global women’s health devices market in 2023 owing to increase in patients seeking diagnosis and treatment for various women's health-related diseases, including various cancers, numerous companies are actively undertaking strategic initiatives to expand their engagement with end-users. For instance, in October 2022, Unified Women's Healthcare has acquired Gennev, thereby expanding its portfolio to encompass menopause relief products throughout the United States. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the increased use of women's health devices in these settings is due to the enhanced convenience and ease they provide to patients.
North America region is anticipated for the highest revenue share during the forecast period owing to the increased healthcare spending on women's health, a rising need for advanced technological devices, a surge in investments from both government and private entities, and a growing awareness of issues related to female health. For instance, in October 2022, The National Women's Health Research Initiative (NWHRI), supported by a USD 20.0 million five-year investment, was a partnership between the Canadian government and Gender Equality and Youth, as stated in Budget 2021. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the expanding healthcare infrastructure, escalating incidence of women's diseases, a heightened awareness of technologically advanced devices for women's health, a rise in product approvals, an uptick in healthcare spending, and an increase in partnerships and collaborations among market entities. For instance, in December 2022, CooperSurgical, Inc. has collaborated with Ostro to introduce a novel consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard. Paragard is an FDA-approved intrauterine device designed to prevent pregnancy for up to 10 years.
Rising focus on the development of new women’s health products is predicted to boost the market growth during the forecast period. Favorable advancements in the field of women's health have inspired a diverse range of companies with various focus areas to invest in the research and development of novel products. Consequently, there has been a notable increase in the number of product launches expected in the forecast period. For instance, in September 2022, Anti-Mullerian Hormone (AMH), a novel direct-to-consumer test, was introduced by Innovative Health Diagnostic.
By application, cancers & other chronic diseases was the highest revenue-grossing segment in the global women’s health devices market in 2023 owing to the growing number of female cancers, the increasing demand for effective medical equipment, and the increasing number of innovative items being released. For instance, in November 2022, Aspira Women's Health introduced OvaWatch to evaluate the risk of ovarian cancer. Additionally, pregnancy & nursing care is predicted to grow at fastest CAGR during the forecast period owing to the growing usage and demand for various essential women's health products, such as breast pumps and pregnancy tests.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global women’s health devices market in 2023 owing to increase in patients seeking diagnosis and treatment for various women's health-related diseases, including various cancers, numerous companies are actively undertaking strategic initiatives to expand their engagement with end-users. For instance, in October 2022, Unified Women's Healthcare has acquired Gennev, thereby expanding its portfolio to encompass menopause relief products throughout the United States. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the increased use of women's health devices in these settings is due to the enhanced convenience and ease they provide to patients.
North America region is anticipated for the highest revenue share during the forecast period owing to the increased healthcare spending on women's health, a rising need for advanced technological devices, a surge in investments from both government and private entities, and a growing awareness of issues related to female health. For instance, in October 2022, The National Women's Health Research Initiative (NWHRI), supported by a USD 20.0 million five-year investment, was a partnership between the Canadian government and Gender Equality and Youth, as stated in Budget 2021. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the expanding healthcare infrastructure, escalating incidence of women's diseases, a heightened awareness of technologically advanced devices for women's health, a rise in product approvals, an uptick in healthcare spending, and an increase in partnerships and collaborations among market entities. For instance, in December 2022, CooperSurgical, Inc. has collaborated with Ostro to introduce a novel consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard. Paragard is an FDA-approved intrauterine device designed to prevent pregnancy for up to 10 years.
Segmentation: Women’s Health Devices Market Report 2023 - 2034
Women’s Health Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Pregnancy & Nursing Care
- Reproductive Health
- General Health & Wellness
- Pelvic & Uterine Healthcare
- Cancers & Other Chronic Diseases
- Others
Women’s Health Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals & Clinics
- Home Healthcare
- Others
Women’s Health Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Women’s Health Devices Market: Application Estimates & Trend Analysis
8. Women’s Health Devices Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Women’s Health Devices Market
11. Europe Global Women’s Health Devices Market
12. Asia Pacific Global Women’s Health Devices Market
13. Latin America Global Women’s Health Devices Market
14. MEA Global Women’s Health Devices Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Prestige Consumer Healthcare Inc.
- Abbott Laboratories
- Hologic
- Caldera Medical
- MedGyn Products
- F. Hoffmann-La Roche
- Medline Industries
- GE Healthcare
- Siemens AG
- Carestream Health
- Koninklijke Philips
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 51.47 Billion |
| Forecasted Market Value ( USD | $ 139.25 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
